ATE432068T1 - Cetirizin und pseudoephedrin enthaltende tablette - Google Patents
Cetirizin und pseudoephedrin enthaltende tabletteInfo
- Publication number
- ATE432068T1 ATE432068T1 AT02743173T AT02743173T ATE432068T1 AT E432068 T1 ATE432068 T1 AT E432068T1 AT 02743173 T AT02743173 T AT 02743173T AT 02743173 T AT02743173 T AT 02743173T AT E432068 T1 ATE432068 T1 AT E432068T1
- Authority
- AT
- Austria
- Prior art keywords
- pseudoephedrine
- tablet containing
- containing cetirizine
- cetirizine
- tablet
- Prior art date
Links
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 title 1
- 229960001803 cetirizine Drugs 0.000 title 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 title 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 title 1
- 229960003908 pseudoephedrine Drugs 0.000 title 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30125001P | 2001-06-28 | 2001-06-28 | |
| EP01115807 | 2001-06-28 | ||
| PCT/EP2002/006342 WO2003002098A1 (en) | 2001-06-28 | 2002-06-10 | Tablet comprising cetirizine and pseudoephedrine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE432068T1 true ATE432068T1 (de) | 2009-06-15 |
Family
ID=56290291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02743173T ATE432068T1 (de) | 2001-06-28 | 2002-06-10 | Cetirizin und pseudoephedrin enthaltende tablette |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1404304B1 (enExample) |
| JP (1) | JP4041460B2 (enExample) |
| KR (1) | KR100926410B1 (enExample) |
| CN (1) | CN100490809C (enExample) |
| AT (1) | ATE432068T1 (enExample) |
| AU (1) | AU2002345024B2 (enExample) |
| BR (1) | BR0210650A (enExample) |
| CA (1) | CA2451519C (enExample) |
| CZ (1) | CZ20033454A3 (enExample) |
| DK (1) | DK1404304T3 (enExample) |
| EE (1) | EE05357B1 (enExample) |
| ES (1) | ES2324769T3 (enExample) |
| HU (1) | HU229803B1 (enExample) |
| MX (1) | MXPA03010430A (enExample) |
| NZ (1) | NZ530289A (enExample) |
| PL (1) | PL206069B1 (enExample) |
| PT (1) | PT1404304E (enExample) |
| RO (1) | RO122476B1 (enExample) |
| RU (1) | RU2286784C2 (enExample) |
| SI (1) | SI1404304T1 (enExample) |
| SK (1) | SK287645B6 (enExample) |
| WO (1) | WO2003002098A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20090029314A (ko) * | 2001-06-28 | 2009-03-20 | 유씨비 파쉼 소시에떼아노님 | 세티리진 및 슈도에페드린을 포함하는 정제 |
| KR100698400B1 (ko) | 2004-04-14 | 2007-03-23 | 이은주 | 탈모증 및 전립선비대증 치료를 위한 약제학적 조성물 |
| US20100172984A1 (en) * | 2006-06-06 | 2010-07-08 | Bijay Kumar Padhi | tablet dosage form comprising cetirizine and pseudoephedrine |
| PT2099442E (pt) | 2006-12-26 | 2015-02-10 | Pharmacyclics Inc | Métodos de utilização de inibidores de histona desacetilase e monitorização de biomarcadores em terapia de combinação |
| US8439033B2 (en) | 2007-10-09 | 2013-05-14 | Microdose Therapeutx, Inc. | Inhalation device |
| CN102665807A (zh) | 2010-01-05 | 2012-09-12 | 微剂量治疗技术公司 | 吸入设备和方法 |
| KR101193495B1 (ko) * | 2010-02-01 | 2012-10-23 | 한미사이언스 주식회사 | 슈도에페드린 및 레보세티리진을 포함하는 경구용 복합 조성물 |
| ES2705244T3 (es) | 2010-06-16 | 2019-03-22 | Inflammatory Response Res Inc | Levocetirizina y montelukast para el tratamiento de la gripe y del resfriado común |
| CN102302497A (zh) * | 2011-05-18 | 2012-01-04 | 天圣制药集团股份有限公司 | 一种治疗过敏性鼻炎的制剂及其制备方法 |
| KR20130009553A (ko) | 2011-07-15 | 2013-01-23 | 한미약품 주식회사 | 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제 |
| UA110853C2 (uk) | 2011-09-13 | 2016-02-25 | Фармасайклікс, Інк. | Лікарські форми інгібітора гістондеацетилази у комбінації з бендамустином та їхнє застосування |
| KR101372324B1 (ko) * | 2012-02-09 | 2014-03-13 | 동국대학교 경주캠퍼스 산학협력단 | 알러지성 비염 치료를 위한 한방 치료제 및 슈도에페드린을 함유한 복합서방형의 약제학적 조성물 |
| EP2968309A4 (en) | 2013-03-13 | 2016-08-31 | Inflammatory Response Res Inc | USE OF LEVOCETRIXIN AND MONTELUKAST IN THE TREATMENT OF VASCULARITY |
| CN105228700A (zh) | 2013-03-13 | 2016-01-06 | 炎症反应研究公司 | 左西替利嗪和孟鲁司特在治疗自身免疫病中的用途 |
| ES2660494T3 (es) | 2013-03-13 | 2018-03-22 | 14779507 | Uso de levocetirizina y montelukast en el tratamiento de una lesión traumática |
| JP2017526728A (ja) | 2014-09-15 | 2017-09-14 | インフラマトリー・レスポンス・リサーチ・インコーポレイテッド | 炎症介在性状態の治療におけるレボセチリジン及びモンテルカスト |
| WO2016140630A1 (en) | 2015-03-05 | 2016-09-09 | PHARMACTIVE ILAÇ SANAYI VE TlCARET A. Ş. | An effervescent composition comprising levocetirizine and pseudoephedrine |
| US20210236430A1 (en) * | 2020-02-03 | 2021-08-05 | Johnson & Johnson Consumer Inc. | Single layer chewable tablet comprising cetirizine |
| WO2021236518A1 (en) | 2020-05-19 | 2021-11-25 | IRR, Inc. | Levocetirizine and montelukast in the treatment of sepsis and symptoms thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6469009B1 (en) * | 1996-04-08 | 2002-10-22 | Ucb, S.A. | Pharmaceutical compositions for the treatment of rhinitis |
| EP0811374A1 (en) * | 1996-05-29 | 1997-12-10 | Pfizer Inc. | Combination dosage form comprising cetirizine and pseudoephedrine |
| BE1011045A3 (fr) * | 1997-03-14 | 1999-04-06 | Ucb Sa | Compositions pharmaceutiques pour la liberation controlee de substances actives. |
| US6267986B1 (en) * | 1999-09-24 | 2001-07-31 | Ranbaxy Laboratories Limited | Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine |
-
2002
- 2002-06-10 HU HU0400386A patent/HU229803B1/hu unknown
- 2002-06-10 RU RU2004101231/15A patent/RU2286784C2/ru active
- 2002-06-10 CA CA002451519A patent/CA2451519C/en not_active Expired - Lifetime
- 2002-06-10 PL PL366800A patent/PL206069B1/pl unknown
- 2002-06-10 PT PT02743173T patent/PT1404304E/pt unknown
- 2002-06-10 WO PCT/EP2002/006342 patent/WO2003002098A1/en not_active Ceased
- 2002-06-10 KR KR1020037017054A patent/KR100926410B1/ko not_active Expired - Lifetime
- 2002-06-10 BR BR0210650-7A patent/BR0210650A/pt not_active Application Discontinuation
- 2002-06-10 ES ES02743173T patent/ES2324769T3/es not_active Expired - Lifetime
- 2002-06-10 EP EP02743173A patent/EP1404304B1/en not_active Expired - Lifetime
- 2002-06-10 CN CNB02812975XA patent/CN100490809C/zh not_active Expired - Lifetime
- 2002-06-10 DK DK02743173T patent/DK1404304T3/da active
- 2002-06-10 RO ROA200301062A patent/RO122476B1/ro unknown
- 2002-06-10 AT AT02743173T patent/ATE432068T1/de active
- 2002-06-10 NZ NZ530289A patent/NZ530289A/en unknown
- 2002-06-10 CZ CZ20033454A patent/CZ20033454A3/cs unknown
- 2002-06-10 AU AU2002345024A patent/AU2002345024B2/en not_active Ceased
- 2002-06-10 SK SK1550-2003A patent/SK287645B6/sk not_active IP Right Cessation
- 2002-06-10 JP JP2003508337A patent/JP4041460B2/ja not_active Expired - Fee Related
- 2002-06-10 SI SI200230844T patent/SI1404304T1/sl unknown
- 2002-06-10 MX MXPA03010430A patent/MXPA03010430A/es active IP Right Grant
- 2002-06-10 EE EEP200400005A patent/EE05357B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1404304A1 (en) | 2004-04-07 |
| HUP0400386A2 (hu) | 2004-08-30 |
| EE05357B1 (et) | 2010-12-15 |
| CA2451519A1 (en) | 2003-01-09 |
| ES2324769T3 (es) | 2009-08-14 |
| RU2286784C2 (ru) | 2006-11-10 |
| PL366800A1 (en) | 2005-02-07 |
| CA2451519C (en) | 2007-11-06 |
| RU2004101231A (ru) | 2005-04-20 |
| BR0210650A (pt) | 2004-10-05 |
| KR100926410B1 (ko) | 2009-11-12 |
| MXPA03010430A (es) | 2004-12-06 |
| HU229803B1 (en) | 2014-07-28 |
| JP4041460B2 (ja) | 2008-01-30 |
| PL206069B1 (pl) | 2010-06-30 |
| JP2004536829A (ja) | 2004-12-09 |
| RO122476B1 (ro) | 2009-07-30 |
| CN100490809C (zh) | 2009-05-27 |
| SI1404304T1 (sl) | 2009-10-31 |
| HUP0400386A3 (en) | 2006-02-28 |
| AU2002345024B2 (en) | 2006-09-07 |
| CZ20033454A3 (cs) | 2004-08-18 |
| SK287645B6 (sk) | 2011-05-06 |
| WO2003002098A1 (en) | 2003-01-09 |
| PT1404304E (pt) | 2009-06-26 |
| NZ530289A (en) | 2004-11-26 |
| KR20040007756A (ko) | 2004-01-24 |
| EP1404304B1 (en) | 2009-05-27 |
| CN1520285A (zh) | 2004-08-11 |
| SK15502003A3 (sk) | 2004-05-04 |
| DK1404304T3 (da) | 2009-07-13 |
| EE200400005A (et) | 2004-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1404304T3 (da) | Tablet omfattende cetirizin og pseudoephedrin | |
| DE50206657D1 (de) | Pharmazeutische zusammensetzung zur behandlung von multiple sklerose | |
| PT1605956E (pt) | Administração de capsaicinóides para o tratamento da osteoartrite | |
| ATE318590T1 (de) | Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen | |
| DE60232251D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von asthma | |
| ATE350375T1 (de) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen | |
| ATE396202T1 (de) | Lang wirkendes glucagon-ähnliches peptid-2 für die behandlung von gastrointestinalen krankheiten und störungen | |
| CY1109238T1 (el) | Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη | |
| DK1546127T3 (da) | Nye pyrimidinamidderivater og anvendelse deraf | |
| PT1392292E (pt) | Piranoindazoles e sua utilizacao para o tratamento de glaucoma | |
| MXPA05012358A (es) | Combinacion farmaceutica que comprende modafinilo y otra droga. | |
| NO20033123D0 (no) | Terapeutisk hinnedannende sammensetning og behandlingsplan derav | |
| DK1781277T3 (da) | Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol | |
| ATE389392T1 (de) | Paracetamol enthaltende tablette | |
| ATE524186T1 (de) | Pharmazeutische kombinationen bestehend aus meloxicam, tramadol und paracetamol | |
| DE50109572D1 (de) | Parental applizierbare darreichungsformen enthaltend eine suspension des salzes aus tramadol und diclofenac | |
| ATE491442T1 (de) | 1-phenyl-2- dimethylaminomethylcyclohexanverbindungen zur therapie von depressiven symptomatiken, schmerz und inkontinenz | |
| ATE402703T1 (de) | Tablette enthaltend efletirizin und pseudoephedrin | |
| SE0004827D0 (sv) | Therapeutic compounds | |
| ATE270551T1 (de) | Kombinationspräparat aus 2-methylthiazolidin-2,4- dicarbonsäure und paracetamol | |
| BG105984A (bg) | Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението | |
| DE60315666D1 (de) | Furopyridin- und furopyrimidinderivate zur behandlung von hyperproliferativen erkrankungen | |
| DE50304524D1 (de) | Arzneimittel enthaltend substituierte 2,5-diaminomethyl-1h-pyrrole | |
| HU0105291D0 (en) | Pharmaceutical compositions for the treatment of indigestion and related diseases | |
| ITMI20020055A0 (it) | Composizione medicinale per il trattamento della degenerazione artilaginea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1404304 Country of ref document: EP |